2012
DOI: 10.1002/phar.1142
|View full text |Cite
|
Sign up to set email alerts
|

Fatal Clindamycin‐Induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Syndrome

Abstract: Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome is a rare, complex, idiosyncratic drug reaction that can be fatal. Systemic symptoms include lymphadenopathy, hepatic failure, and possibly renal failure. The syndrome has been primarily associated with anticonvulsants, whereas antimicrobials are less commonly associated. We describe a 63-year-old woman who initially presented with rash and acute kidney injury secondary to treatment with clindamycin for a methicillin-susceptible Staphylococcus … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0
2

Year Published

2013
2013
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(8 citation statements)
references
References 13 publications
0
6
0
2
Order By: Relevance
“…Her condition rapidly deteriorated despite the fast discontinuation of the medication and even IVIG administration. Hepatic involvement is proposed a predictor of poor prognosis in this patient [ 68 ]. However, the two other cases also experienced liver involvement but survived.…”
Section: Discussionmentioning
confidence: 99%
“…Her condition rapidly deteriorated despite the fast discontinuation of the medication and even IVIG administration. Hepatic involvement is proposed a predictor of poor prognosis in this patient [ 68 ]. However, the two other cases also experienced liver involvement but survived.…”
Section: Discussionmentioning
confidence: 99%
“…Conversely, not all patients treated with clindamycin develop kidney diseases. The exact mechanism of clindamycin-induced AKI requires further study (11)(12)(13).…”
Section: Discussionmentioning
confidence: 99%
“…Facial skin and oral mucosa were always reported as the initial site of such a lesion (Croy, Buehrle, & Austin Szwak, 2017; Karakayali et al., 2017; Sampson, Klinkova, Vitko, & Casanas, 2018), some of which sometimes occurred only in oral‐maxillofacial system (Nitta et al., 2019). Additionally, other severe cutaneous lesions attacking oral‐maxillofacial part were also investigated, such as drug reaction with eosinophilia and systemic symptoms (Miller Quidley, Bookstaver, Gainey, & Gainey, 2012; Tian, Mohan, & Stallings, 2010), hypersensitivity syndrome (Nakamura, Watamatsu, & Muto, 2013; Papakonstantinou et al., 2018), and sweet syndrome (Kandula, Burke, & Goldfarb, 2010).…”
Section: Oral‐maxillofacial Adverse Events Related To Antimlarialsmentioning
confidence: 99%